JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 46(2012) N 4 p. 579-587;
A.V. Timokhova1, L.V. Bakinovskii2, A.I. Zinin2, V.I. Popenko1, A.V. Ivanov1, P.M. Rubtsov1, S.N. Kochetkov1, S.N. Beljelarskaya1*

Effect of Deoxynojirimycin Derivatives on Morphogenesis of Hepatitis C Virus

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia
2Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, 119991 Russia

*belj@eimb.ru
Received - 2011-11-09; Accepted - 2011-12-29

Viral hepatitis C is a dangerous, widespread human disease. The choice of drugs for treatment of chronic hepatitis C virus (HCV) infection is limited, and prophylactic vaccines do not exist. Thus, the development of new antiviral strategies and substances is an issue of great importance. The targeting of viral morphogenesis might be used as an alternative approach to existing strategies of HCV blocking. The glycosylation of viral envelope proteins is an important step of viral particle morphogenesis, which determines the correct assembly of HCV virions. Derivatives of a glucose analog deoxynojirimycin (DNJ) act as an α-glucosidase inhibitor and can impair the assembly of structural proteins and HCV particle formation. In the present work, the effects of alkylated DNJ derivatives, N-pentyl-DNJ and N-benzyl-DNJ, on HCV morphogenesis were studied in a model system of insect cells that produce three viral structural proteins with the formation of virus-like particles. It was shown that DNJ derivatives impair the intracellular N-glycosylation of HCV envelope glycoproteins. At the concentration of 1 mM, these substances cause an increase in the levels of gpE1 and gpE2 gly-coproteins and a decrease in their electrophoretic mobility, apparently due to the inhibition of α-glucosidase in the endoplasmic reticulum and the accumulation of hyperglycosylated N-glycans in HCV glycoproteins. The interaction of the latter with calnexin results in the formation of unproductive dimers and blocks the productive assembly of virus-like particles.

baculovirus AcMNPV, hepatitis C virus (HCV), HCV structural proteins, HCV glycoproteins, HCV-like particles (VLPs), Sf9 insect cells, deoxynojirimycin (DNJ), NBnDNJ, NPnDNJ, NBDNJ, α-glucosidase, calnexin, calreticulin



JMB-FOOTER RAS-JOURNALS